Armistice Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Armistice Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $9.51 Million - $12.2 Million	700,000 Added 13.46%	5,900,000 $92.8 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $5.94 Million - $9.73 Million	588,000 Added 12.75%	5,200,000 $83.9 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $647,920 - $804,960	52,000 Added 1.14%	4,612,000 $58.7 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $6.11 Million - $7.34 Million	460,000 Added 11.22%	4,560,000 $64.2 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $15.3 Million - $23.7 Million	-1,072,000 Reduced 20.73%	4,100,000 $63.3 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $6 Million - $7.69 Million	404,000 Added 8.47%	5,172,000 $84.8 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $7.82 Million - $12.8 Million	-632,000 Reduced 11.7%	4,768,000 $88.2 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $3.97 Million - $6.1 Million	-436,000 Reduced 7.47%	5,400,000 $71 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $16.5 Million - $26.7 Million	2,405,846 Added 70.14%	5,836,000 $54.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $21.2 Million - $102 Million	2,752,154 Added 405.92%	3,430,154 $33.5 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $5.45 Million - $7.65 Million	206,000 Added 43.64%	678,000 $23 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $15.4 Million - $22.6 Million	472,000 New	472,000 $17.3 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.